Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject vs. Venofer for Iron Deficiency Anemia in Pregnancy
NCT06061393Phase 4Recruiting
- Sponsor
- Galilee Medical Center
- Start
- Nov 2023
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose and iron sucrose in iron deficiency anemia (IDA) (2 arms), sponsored by Galilee Medical Center. Primary endpoints: Ratio of women with Hemoglobin level > 11 at delivery and Postpartum Hemoglobin level. Started Nov 2023; status: recruiting.
02
Drugs
ferric carboxymaltoseiron sucrose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06061393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06061393.